AKR1C3 and neoplasm: Our target gene, the Aldo-keto reductase family 1 member C3 (AKR1C3) gene, has been reported to be highly expressed in breast malignancies and is associated with tumor invasiveness, aggression, and resistance to chemotherapy [16,17].